Shop by goal

Popular compounds

GHK-Cu

GLP1-RC-RT

Research resources

PEG-MGF Explained: What PEGylation Changes and What the Evidence Covers

PEG-MGF is the 24-residue E-domain peptide of an IGF-1 splice variant, called mechano growth factor, with polyethylene glycol attached. PEGylation is a standard way to slow clearance, but we found no published study that measures PEG-MGF’s pharmacokinetics . The underlying MGF research is contested: early work reported effects on muscle stem cells independent of the IGF-1 receptor, while a later two-company replication attempt found none. It is unapproved and research material only.

The science here is unsettled, not just early. The studies cited are cell-culture and animal experiments, and they disagree with each other. Half-life figures quoted for PEG-MGF online are not from a measured study we could find. Research context only; nothing here is medical or dosing guidance.

At a glance

PEG-MGF Core peptide The 24-amino-acid MGF E-peptide, YQPPSTNKNTKSQRRKGSTFEERK (about 2.9 kDa before PEG) Gene origin A splice variant of the IGF-1 gene: IGF-1Ec in humans, IGF-1Eb in rodents Modification Polyethylene glycol (PEG) attached; chain size varies by supplier, so total mass varies Human data None found for PEG-MGF; cell and animal work on unmodified MGF Approval None; MGF is prohibited in sport by WADA

Where MGF came from

The IGF-1 gene can be spliced into different forms. A group at University College London led by Geoffrey Goldspink reported that muscle expresses a splice variant, later named mechano growth factor, in response to mechanical signals. In rabbit muscle, stretch upregulated both IGF-1 forms within four days, and the authors described the second isoform as apparently designed for autocrine and paracrine action (McKoy et al., J Physiol , 1999). In rat muscle after local damage was expressed rapidly and then declined over a few days, with satellite-cell markers following it (Hill & Goldspink, J Physiol , 2003).

Those are expression studies: they show the variant is made after damage, not what a synthetic copy does when given to an animal or a person. The synthetic 24-residue E-peptide is what the research-market compound is built on.

The contested part

The claim behind PEG-MGF is that the E-peptide itself activates muscle stem cells through a route independent of the IGF-1 receptor. The literature splits:

Supporting. Yang and Goldspink (2002) reported that the MGF E domain increased myoblast proliferation and inhibited terminal differentiation, and that blocking the IGF-1 receptor suggested a different receptor was involved. Kandalla et al. (2011) reported that a 24-residue MGF-E peptide increased the proliferative lifespan of satellite cells from neonatal and young adult human muscle, but not from old adult muscle.

Not reproduced. Fornaro et al. (2014), working at two pharmaceutical companies, tried to reproduce the claimed effects. Concentrations up to 500 ng/ml failed to increase proliferation of C2C12 cells or primary human myoblasts, failed to inhibit differentiation, and showed no significant effect in primary mouse muscle stem cells, while mature IGF-1 did. The authors said their results “call in to question whether there is a physiological role for MGF.”

Receptor-dependent. Brisson and Barton (2012) found that E-peptide effects on signalling, proliferation and migration depended on the IGF-1 receptor, and proposed that E-peptides have little independent activity and instead modulate IGF-1 signalling.

So the mechanism usually attached to PEG-MGF, a receptor-independent route, is one side of an open disagreement in the primary literature.

What PEGylation adds, and what has not been shown

PEGylation attaches polyethylene glycol to a molecule to make it larger and more resistant to clearance. It is a real tool: a PEGylated recombinant IGF-1 studied in 62 healthy volunteers had a measured half-life of 140–200 hours (Kletzl et al., 2017). That number belongs to that construct, made and characterised by one company, and it shows that the PEG design determines the result.

For PEG-MGF, the half-life figures of “hours to days” that circulate online are not attached to a published measurement that we could find, and PEG chain size differs between suppliers, which alone would change the answer. A PubMed search for a PEG-MGF pharmacokinetic study returns none.

Status, evidence tier and identity

A 2026 endocrinology review places PEG-MGF and IGF-1 LR3 among the GH–IGF-1 axis compounds sold as research chemicals, stratifies the class from regulatory-grade trial data down to a complete absence of human studies, and flags biologically plausible but unproven mitogenic concerns (Dominikowski et al., 2026). MGF is prohibited in sport by WADA.

Identity is harder for a PEGylated peptide. PEG chains are not a single uniform mass, so a PEGylated peptide gives a spread of masses rather than one sharp peak, and a single HPLC purity figure is less informative. Documentation should state the PEG size and the method used. See how to read a certificate of analysis.

Research takeaway

PEG-MGF is the MGF E-peptide with polyethylene glycol attached; the PEG size is supplier-specific.

The MGF mechanism is contested: positive cell studies, a two-company failure to reproduce, and a finding of IGF-1 receptor dependence.

We found no published pharmacokinetic or human study of PEG-MGF; quoted half-lives are unsourced.

It is unapproved is prohibited in sport, and it is sold as laboratory research material only.

Primary sources

Journal of Physiology — Expression of insulin growth factor-1 splice variants and structural genes in rabbit skeletal muscle induced by stretch and stimulation (McKoy et al., 1999)

FEBS Letters — Different roles of the IGF-I Ec peptide (MGF) and mature IGF-I in myoblast proliferation and differentiation (Yang & Goldspink, 2002)

Journal of Physiology — Expression and splicing of the insulin-like growth factor gene in rodent muscle is associated with muscle satellite (stem) cell activation following local tissue damage (Hill & Goldspink, 2003)

Mechanisms of Ageing and Development — Mechano Growth Factor E peptide (MGF-E) activates human muscle progenitor cells and induces an increase in their fusion potential at different ages (Kandalla et al., 2011)

PLoS ONE — Insulin-like growth factor-I E-peptide activity is dependent on the IGF-I receptor (Brisson & Barton, 2012)

American Journal of Physiology: Endocrinology and Metabolism — Mechano-growth factor peptide, the COOH terminus of unprocessed insulin-like growth factor 1, has no apparent effect on myoblasts or primary muscle stem cells (Fornaro et al., 2014)

Growth Hormone & IGF Research — First-in-man study with a novel PEGylated recombinant human insulin-like growth factor-I (Kletzl et al., 2017)

Frontiers in Endocrinology — The emerging landscape of performance-enhancing peptides modulating the GH-IGF1 axis (Dominikowski et al., 2026)

Background

World Anti-Doping Agency — Prohibited List (class S2: peptide hormones, growth factors, related substances and mimetics)

PEG-MGF as laboratory research material

New-U lists PEG-MGF as laboratory research material. The studies above describe published cell and animal work on not this material. Research use only – all claims made on this site are for testing and research use only.

Frequently asked questions

What is PEG-MGF?

PEG-MGF is the 24-amino-acid E-peptide of an IGF-1 splice variant, called mechano growth factor, with polyethylene glycol attached. It is sold as research material and has no approved use.

What does PEGylation do?

PEGylation attaches polyethylene glycol to a molecule to make it larger and more resistant to clearance. The result depends on the construct: a PEGylated IGF-1 measured in healthy volunteers had a half-life of 140 to 200 hours, but no equivalent measurement exists for PEG-MGF that we could find.

Is there human evidence for PEG-MGF?

We found no published human or pharmacokinetic study of PEG-MGF. The underlying work on unmodified MGF is cell-culture and animal research, and its results disagree: one group reported stem-cell effects while a two-company replication attempt found none.

Is PEG-MGF the same as IGF-1 LR3?

No. PEG-MGF is built on the E-peptide, the tail cut from the IGF-1 precursor. IGF-1 LR3 is an analogue of mature IGF-1 itself. They are different molecules with different literatures.

Is PEG-MGF approved or allowed in sport?

No. PEG-MGF has no approved use, and mechano growth factors are prohibited in sport by WADA. It is supplied for laboratory research only, not for human consumption.

External links are provided for research reference only; New-U is not affiliated with the cited organisations or authors. All figures are published study results shown for research context, not dosing guidance. New-U Research Compounds supplies research compounds strictly for laboratory research use only — not for human consumption .

Part of the Tissue repair & recovery research research area — explore related compounds, guides and sources.

PRECISION. PURITY. PERFORMANCE.

Research peptides at >99% HPLC-verified purity, third-party tested by Janoshik Analytical & Freedom Diagnostics, with Certificates of Analysis published per released batch. Supplied strictly for laboratory research use.

Shop

All research compounds

Price list

Where to buy peptides

Research